<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615118/" ref="ordinalpos=605&amp;ncbi_uid=4782975&amp;link_uid=PMC3615118" image-link="/pmc/articles/PMC3615118/figure/pone-0060078-g002/" class="imagepopup">Figure 2. LPS-liposomes induce the TRIF-dependent <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> but not the MyD88-dependent <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Liposomal Lipopolysaccharide Initiates TRIF-Dependent <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Independent of CD14. </a></div><br /><div class="p4l_captionBody">Thioglycollate-elicited peritoneal macrophages (1×106 cells) from WT mice were stimulated with LPS (100 ng/mL) or LPS-liposomes (100 ng/mL) for 0–120 min. The cells were then lysed and the extracts immunoblotted with anti-IRF3 (A), anti-IκBα antibodies (B), or anti-IRAK and anti-MAPK antibodies (C). Data are average of three independent experiments and band intensity was quantified with Image J 1.45. The values represent means ± S.E.M <b>*</b>P&lt;0.05.</div></div>